PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

Burma | Chicago
Scientist 🥼🧪🔬
Covering companies shaping healthcare 🏥

Stream new episodes, available on all podcast platforms!

PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

Episode 4: Johnson & Johnson

April 02, 2025 • Manead Khin • Season 1 • Episode 4

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J)—one of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids, Tylenol, and Johnson’s Baby Powder, J&J has shaped modern medicine in countless ways.

We’ll explore how Robert Wood Johnson I, alongside his brothers, turned a struggling startup into a global powerhouse by pioneering antiseptic surgical techniques, mass-market first-aid products, and cutting-edge medical devices. Along the way, we’ll also discuss J&J’s resilience through major challenges—like the 1982 Tylenol crisis, which redefined corporate crisis management.

Fast forward to today, and J&J is still at the forefront of innovation, investing heavily in robotics, gene therapy, and AI-driven healthcare solutions.

🎧 Grab a coffee and tune in for a fast-paced, insightful breakdown of J&J's journey!

Support the show

Intro

🎙️ [Upbeat music fades in]
Hello and welcome to Petri Dish Perspectives: Biotech Unleashed, the podcast where we geek out about science and companies shaping the future of healthcare. I’m your host, Manead, and I’m a scientist with a PhD background in cancer biology and analytical chemistry. With every episode, my goal is to deliver digestible pieces of information on healthcare companies under 30 mins. Today we’re diving into the story of Johnson & Johnson or JnJ — a company that emerged as a leader in drug store brands. In 2024, JnJ was named a 2024 Fortune World’s Most Admired Company. This is the company I was familiar with even back when I was a kid, growing up in Burma.

Quick disclaimer, I give full credit to the original articles cited in the references in the transcript!

Grab a coffee or tea, settle in, and let’s jump in!
[Music fades out]

Segment 1: Founding Story

Let’s turn back the clock to the late 19th century. Robert Wood Johnson I was born on February 20, 1845, in Carbondale, Pennsylvania, and grew up with his two siblings, James Wood Johnson and Edward Mead Johnson. He attended public schools and Wyoming Seminary in Pennsylvania. In 1861, Johnson began an apprenticeship at Wood & Tittmer, an apothecary in the state of New York, before moving on to work for Roushton & Aspinwall, a drug company, in New York City in 1864. So, even when he was in his teenage years, he was very familiar with the world of drugs and medicines.

While at Roushton & Aspinwall, he met George J. Seabury, and together they founded Seabury & Johnson, a company focused on sterile surgical products inspired by Joseph Lister's antiseptic principles. Johnson worked 12-hour days to develop aseptic surgical equipment, and by 1878, the company was generating $10,000 per month (over $325,000 in today's money). However, disputes over profit distribution and family involvement led to Johnson selling his shares to Seabury in 1880, agreeing to stay out of the medical business for ten years.

After leaving Seabury & Johnson, Robert Wood Johnson I re-entered the medical industry when Seabury was unable to continue making agreed-upon payments. In exchange for canceling the payments, Seabury allowed Johnson to return to the field. Seabury & Johnson continued to exist as a separate entity.

Meanwhile, James Wood Johnson and Edward Mead Johnson had founded Johnson & Johnson in 1886 with just 14 employees, but the company struggled financially. When Robert joined his brothers' firm, he provided the capital needed for a fresh start. In return, he received 50% ownership and took over management, while his brothers each held 30%. Robert commuted between the New Brunswick, New Jersey factory and the New York office, and by early 1888, Johnson & Johnson was generating $25,000 per month (equivalent to $875,000 today). By 1888, the company published the first comprehensive manual on antiseptic surgical techniques, further solidifying their position as thought leaders in the healthcare industry.

Edward Mead Johnson eventually left the company in 1895 to form what would become Mead Johnson Nutrition, focusing on infant and child nutrition. Meanwhile, Robert and James continued to expand Johnson & Johnson, laying the groundwork for a healthcare empire. In 1896, Seabury and Johnson was taken over by Johnson & Johnson.

Segment 2: Early Growth and Milestones

The early years of Johnson & Johnson were marked by rapid growth and groundbreaking achievements. In 1894, the company introduced one of its most iconic products: Johnson’s Baby Powder. This simple yet transformative product not only addressed skin irritation but also became a symbol of trust and care for families around the world. It was the beginning of J&J’s foray into consumer health, an area where they would eventually dominate.

By the turn of the century, the company had expanded its portfolio to include a wide range of medical and consumer products, from sutures to household first-aid kits. These kits made first aid accessible to everyday people, a novel idea at the time. Johnson & Johnson became synonymous with safety, innovation, and reliability.

One of the company’s most notable early milestones came during the Spanish-American War in 1898. J&J provided soldiers with sterilized surgical dressings and first-aid supplies, demonstrating their ability to respond quickly to public health crises. This commitment to serving public health would become a defining characteristic of the company.

Throughout the 20th century, J&J continued to pioneer advancements in healthcare. From the introduction of Band-Aid adhesive bandages in 1920 to their leadership in mass-producing penicillin during World War II, the company proved time and again that it could innovate on a global scale. These milestones weren’t just business successes; they were life-saving contributions that cemented Johnson & Johnson’s role as a healthcare leader.

Sadly, Johnson & Johnson’s original founders, brothers Robert, James, and Edward Mead Johnson, died in 1910, 1932, and 1911 respectively. IPO for JnJ came much later. Johnson & Johnson went public on September 24, 1944, with its initial public offering (IPO) listed on the New York Stock Exchange. The price of each J&J share was $37.50. At the time of IPO, Philip B. Hofmann, who was an American businessman, was the CEO. He was the first non-family-member to serve as chairman and CEO of the healthcare firm Johnson & Johnson.

Segment 3: Blockbuster Products and Innovations

Johnson & Johnson’s portfolio includes some of the most iconic and impactful healthcare products of all time. Let’s take a look at a few of their major contributions:

Band-Aid Adhesive Bandages: Invented in 1920 by Johnson & Johnson employee Earle Dickson, Band-Aid adhesive bandages were born out of a simple yet pressing household need. Dickson's wife frequently suffered from small cuts and burns while cooking and doing household chores, and he wanted to create a quick and easy way for her to dress minor wounds without assistance. His innovation—a small pad of gauze affixed to adhesive tape—became a game-changer in first aid. Johnson & Johnson quickly recognized the potential and began mass-producing Band-Aids in 1924, initially distributing them for free to Boy Scout troops across the country. Over the years, Band-Aids evolved with waterproof coatings, fun designs for kids, and specialized versions for different types of wounds. Today, Band-Aid remains a household staple and a globally recognized brand, with billions of bandages sold each year, making wound care accessible and convenient for people of all ages.
Tylenol (Acetaminophen): Tylenol, a brand name for acetaminophen, has been a cornerstone of pain and fever relief for decades. While acetaminophen was first synthesized in the late 19th century, Johnson & Johnson acquired McNeil Laboratories in 1959, bringing Tylenol into its product portfolio and revolutionizing over-the-counter pain management. Unlike aspirin, Tylenol provided effective pain relief without causing stomach irritation or blood-thinning effects, making it a preferred choice for many patients. However, one of the most defining moments in the history of Tylenol—and corporate crisis management—came in 1982 when an unknown individual tampered with Tylenol bottles, lacing capsules with cyanide, leading to several deaths. Johnson & Johnson’s swift, transparent, and consumer-focused response set new industry standards for crisis management. The company immediately recalled 31 million bottles, introduced tamper-evident packaging, and launched an unprecedented public safety campaign to regain consumer trust. Despite the setback, Tylenol rebounded and remains one of the most widely used and trusted pain relievers worldwide, generating billions in annual sales.
Baby Care Products: For over a century, Johnson & Johnson’s baby care line has been a staple in households, earning the trust of generations of parents. The company’s first baby product, Johnson’s Baby Powder, was introduced in 1894, following reports that its medicated plasters were causing skin irritation. To help soothe babies’ delicate skin, J&J developed a talc-based powder, which quickly became a nursery essential. In 1953, Johnson & Johnson launched its "No More Tears" Baby Shampoo, pioneering a gentle, tear-free formula that revolutionized hair care for infants. Over the years, the company expanded its product range to include baby lotions, washes, and wipes, all designed with dermatologists and pediatricians to ensure the highest safety standards. Despite some controversy regarding talc-based baby powder and its alleged links to health concerns, J&J has maintained a strong reputation in baby care. The brand’s commitment to gentle, effective formulations continues to make its products a go-to choice for parents worldwide.
Medical Devices: Johnson & Johnson is a global leader in the medical devices industry, offering innovative solutions across various fields, from surgical instruments to orthopedic implants and cardiovascular technology. Through its subsidiaries like Ethicon, DePuy Synthes, and Biosense Webster, J&J has helped shape modern surgery and improve patient outcomes.

Surgical Innovations: J&J’s subsidiary Ethicon has been a pioneer in surgical sutures, minimally invasive procedures, and robotic-assisted surgery. Their staplers and laparoscopic tools have enhanced precision and reduced recovery times for millions of patients.
Orthopedic Breakthroughs: With DePuy Synthes, Johnson & Johnson is at the forefront of joint replacement and spinal care, providing cutting-edge implants and devices that help restore mobility and quality of life for patients with orthopedic conditions.
Cardiac and Neurological Devices: Through Biosense Webster, J&J has made significant advancements in electrophysiology, helping doctors treat heart arrhythmias and neurological disorders with state-of-the-art medical technology.

These products are more than just commercial successes; they are milestones that reflect J&J’s commitment to improving human health.

Segment 4: Keys to Success

What has made Johnson & Johnson so successful over the years? Let’s break it down:

Diversified Portfolio: J&J operates in three key sectors — pharmaceuticals, medical devices, and consumer health — providing a balanced approach that ensures resilience.
Commitment to Quality: From their earliest surgical dressings to modern-day vaccines, J&J has always prioritized quality and safety.
Global Reach: With operations in over 60 countries and products sold in more than 175, J&J’s impact is truly global.
Corporate Credo: Introduced in 1943, the J&J Credo emphasizes responsibility to patients, employees, communities, and shareholders, guiding the company’s decisions to this day.

Segment 5: The People Behind J&J

From its founders to its modern leadership, Johnson & Johnson’s story is driven by visionary individuals. Robert Wood Johnson, often called the “General,” not only built the company but also established its guiding principles. His influence can still be felt in J&J’s corporate culture today.

Segment 6: What’s Next?

Johnson & Johnson is poised for an exciting future as it continues to innovate and expand. The company is heavily investing in cutting-edge fields like gene therapy, precision medicine, and digital health. Through its pharmaceutical division, Janssen, J&J is advancing treatments for complex diseases like Alzheimer’s, multiple myeloma, and rare genetic disorders.

In the consumer health space, J&J recently announced a renewed focus on sustainability, aiming to make its products more eco-friendly and ethically sourced. Initiatives like recyclable packaging and reduced carbon emissions highlight its commitment to corporate responsibility.

Another major focus is robotics and minimally invasive surgery. With its acquisition of Auris Health, J&J is at the forefront of robotic-assisted surgical technologies, aiming to make procedures safer and more efficient for patients and doctors alike.

The company is also embracing digital transformation, using AI and data analytics to accelerate drug discovery and improve patient outcomes. These efforts ensure that Johnson & Johnson remains a leader in healthcare innovation, ready to tackle the challenges of tomorrow.

By the time the episode was recorded, JNJ stock sat at $165.72 a piece compared to about $38 when it IPO’ed. While JNJ started out as a family business, today, institutional investors (like mutual funds, hedge funds, and pension funds) hold the majority of JNJ shares.

Outro

🎙️ [Upbeat music fades in]
Thanks for tuning in to this episode of Petri Dish Perspectives. I hope you enjoyed diving into the fascinating story of Johnson & Johnson and its contributions to global health. Don’t forget to subscribe, leave a review, and share this episode with your biotech nerds. Have a topic or company you’d like us to cover? Let me know! Until next time, stay curious and keep exploring the science shaping our world!
[Music crescendos and fades out]

References

People on this episode

Manead Khin

Host